Phone system helps heart failure patients spot symptoms early
NCT ID NCT04347759
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a phone-based system that helps people with heart failure monitor their symptoms and get coaching on how to manage them at home. 50 patients used the system after being discharged from the hospital. The goal was to see if the system could help patients better care for themselves and recognize worsening symptoms early.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Started
-
Feb 2023
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Medical diagnosis of heart failure * New York Heart Association (NYHA) Classification of the Stages of Heart Failure Class I - IV * Ability to read, understand, and speak in English * Will be discharged home * Has daily access to any type of telephone Exclusion Criteria: * A score of 0 or 1-2 with an abnormally drawn clock on the Mini-Cog * Discharged home on hospice care * End-stage renal failure * Wait list for heart transplant
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory Clinic
Atlanta, Georgia, 30322, United States
-
Emory University Hospital
Atlanta, Georgia, 30322, United States
-
Emory University Hospital Midtown
Atlanta, Georgia, 30308, United States
-
University of Utah Health
Salt Lake City, Utah, 84112, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can AI read heart ultrasounds as well as trained sonographers?
- Can modern heart failure drugs reverse damage in three months?